Clinical trial
Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With…
NCT00264901 · Novo Nordisk A/S, Industry · Completed
Key facts
| NCT number | NCT00264901 |
|---|---|
| Title | Comparison of Self Adjustment Versus Standard of Care Treatment in Subjects With Type 2 Diabetes |
| Official title | Impact of a Self-Adjusted Titration Guideline in Subjects With Type 2 Diabetes Mellitus: A Treat-to-Target of the Efficacy and Safety of Levemir® (Insulin Detemir [rDNA Origin] Injection) (PREDICTIVE™ 303) |
| Acronym | PREDICTIVE™ |
| Lead sponsor | Novo Nordisk A/S, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Diabetes, Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | insulin detemir |
| Enrollment | 5,652 |
| Start date | Oct 1, 2005 |
| Primary completion | Nov 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Dec 13, 2005 |
| Last update posted | Jan 31, 2017 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: